INC Research to merge with private-equity owned InVentiv Health in all-stock deal
May 10, 2017 at 07:27 AM EDT
Deal values InVentiv at $4.6 billion, including debt, and will create a large biopharmaceutical outsourcing provider.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
